Literature DB >> 16260730

Mullerian inhibiting substance acts as a motor neuron survival factor in vitro.

Pei-Yu Wang1, Kyoko Koishi, Andrew B McGeachie, Michael Kimber, David T Maclaughlin, Patricia K Donahoe, Ian S McLennan.   

Abstract

The survival of motor neurons is controlled by multiple factors that regulate different aspects of their physiology. The identification of these factors is important because of their relationship to motor neuron disease. We investigate here whether Mullerian Inhibiting Substance (MIS) is a motor neuron survival factor. We find that motor neurons from adult mice synthesize MIS and express its receptors, suggesting that mature motor neurons use MIS in an autocrine fashion or as a way to communicate with each other. MIS was observed to support the survival and differentiation of embryonic motor neurons in vitro. During development, male-specific MIS may have a hormone effect because the blood-brain barrier has yet to form, raising the possibility that MIS participates in generating sex-specific differences in motor neurons.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260730      PMCID: PMC1283469          DOI: 10.1073/pnas.0508304102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

2.  Physiological changes in ageing muscles.

Authors:  M J Campbell; A J McComas; F Petito
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

Review 3.  Transduction pathway of anti-Müllerian hormone, a sex-specific member of the TGF-beta family.

Authors:  Nathalie Josso; Nathalie di Clemente
Journal:  Trends Endocrinol Metab       Date:  2003-03       Impact factor: 12.015

4.  Interleukin-6 protects anterior horn neurons from lethal virus-induced injury.

Authors:  Kevin D Pavelko; Charles L Howe; Kristen M Drescher; Jeff D Gamez; Aaron J Johnson; Tao Wei; Richard M Ransohoff; Moses Rodriguez
Journal:  J Neurosci       Date:  2003-01-15       Impact factor: 6.167

5.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death.

Authors:  Diether Lambrechts; Erik Storkebaum; Masafumi Morimoto; Jurgen Del-Favero; Frederik Desmet; Stefan L Marklund; Sabine Wyns; Vincent Thijs; Jörgen Andersson; Ingrid van Marion; Ammar Al-Chalabi; Stephanie Bornes; Rhiannon Musson; Valerie Hansen; Lars Beckman; Rolf Adolfsson; Hardev Singh Pall; Hervé Prats; Severine Vermeire; Paul Rutgeerts; Shigehiro Katayama; Takuya Awata; Nigel Leigh; Loïc Lang-Lazdunski; Mieke Dewerchin; Christopher Shaw; Lieve Moons; Robert Vlietinck; Karen E Morrison; Wim Robberecht; Christine Van Broeckhoven; Désiré Collen; Peter M Andersen; Peter Carmeliet
Journal:  Nat Genet       Date:  2003-08       Impact factor: 38.330

6.  Visualizing sexual dimorphism in the brain.

Authors:  Nirao M Shah; David J Pisapia; Silas Maniatis; Monica M Mendelsohn; Adriana Nemes; Richard Axel
Journal:  Neuron       Date:  2004-08-05       Impact factor: 17.173

Review 7.  Enhanced purification and production of Müllerian inhibiting substance for therapeutic applications.

Authors:  Patricia K Donahoe; Trent Clarke; Jose Teixeira; Shyamala Maheswaran; David T MacLaughlin
Journal:  Mol Cell Endocrinol       Date:  2003-12-15       Impact factor: 4.102

8.  Immunocytochemical detection of anti-müllerian hormone in Sertoli cells of various mammalian species including human.

Authors:  D Tran; J Y Picard; J Campargue; N Josso
Journal:  J Histochem Cytochem       Date:  1987-07       Impact factor: 2.479

9.  The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over.

Authors:  Raeburn B Forbes; Shuna Colville; Robert J Swingler
Journal:  Age Ageing       Date:  2004-03       Impact factor: 10.668

Review 10.  Novel functions and signalling pathways for GDNF.

Authors:  Hannu Sariola; Mart Saarma
Journal:  J Cell Sci       Date:  2003-10-01       Impact factor: 5.285

View more
  38 in total

1.  CAR T Cells Targeting MISIIR for the Treatment of Ovarian Cancer and Other Gynecologic Malignancies.

Authors:  Alba Rodriguez-Garcia; Prannda Sharma; Mathilde Poussin; Alina C Boesteanu; Nicholas G Minutolo; Sarah B Gitto; Dalia K Omran; Matthew K Robinson; Gregory P Adams; Fiona Simpkins; Daniel J Powell
Journal:  Mol Ther       Date:  2019-12-06       Impact factor: 11.454

2.  Mullerian inhibiting substance inhibits invasion and migration of epithelial cancer cell lines.

Authors:  Henry L Chang; Rafael Pieretti-Vanmarcke; Fotini Nicolaou; Xianlin Li; Xiaolong Wei; David T MacLaughlin; Patricia K Donahoe
Journal:  Gynecol Oncol       Date:  2010-11-06       Impact factor: 5.482

3.  The anti-aging effects of Ludwigia octovalvis on Drosophila melanogaster and SAMP8 mice.

Authors:  Wei-Sheng Lin; Jun-Yi Chen; Jo-Chiao Wang; Liang-Yu Chen; Che-Hao Lin; Tsung-Ren Hsieh; Ming-Fu Wang; Tsai-Feng Fu; Pei-Yu Wang
Journal:  Age (Dordr)       Date:  2013-12-13

Review 4.  Emerging Roles of Anti-Müllerian Hormone in Hypothalamic-Pituitary Function.

Authors:  Anne-Laure Barbotin; Maëliss Peigné; Samuel Andrew Malone; Paolo Giacobini
Journal:  Neuroendocrinology       Date:  2019-07-05       Impact factor: 4.914

5.  Circulating anti-Müllerian hormone (AMH) associates with the maturity of boys' drawings: Does AMH slow cognitive development in males?

Authors:  Kirstie Morgan; Ted Ruffman; David K Bilkey; Ian S McLennan
Journal:  Endocrine       Date:  2017-06-07       Impact factor: 3.633

6.  Müllerian inhibiting substance is anterogradely transported and does not attenuate avulsion-induced death of hypoglossal motor neurons.

Authors:  Andrew N Clarkson; Caroline L Talbot; Pei-Yu Wang; David T MacLaughlin; Patricia K Donahoe; Ian S McLennan
Journal:  Exp Neurol       Date:  2010-12-30       Impact factor: 5.330

7.  Anti-mullerian hormone is higher in seizure-free women with epilepsy compared to those with ongoing seizures.

Authors:  Cynthia L Harden; Page B Pennell; Jacqueline A French; Anne Davis; Connie Lau; Nichelle Llewellyn; Benjamin Kaufman; Emilia Bagiella; Ariel Kirshenbaum
Journal:  Epilepsy Res       Date:  2016-08-17       Impact factor: 3.045

8.  Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior.

Authors:  Pei-Yu Wang; Anna Protheroe; Andrew N Clarkson; Floriane Imhoff; Kyoko Koishi; Ian S McLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

9.  The Müllerian inhibiting substance type 2 receptor suppresses tumorigenesis in testes with sustained β-catenin signaling.

Authors:  Pradeep S Tanwar; Arno E Commandeur; LiHua Zhang; Makoto M Taketo; Jose M Teixeira
Journal:  Carcinogenesis       Date:  2012-09-07       Impact factor: 4.944

10.  Development of an efficiently cleaved, bioactive, highly pure FLAG-tagged recombinant human Mullerian Inhibiting Substance.

Authors:  Thanos D Papakostas; Rafael Pieretti-Vanmarcke; Fotini Nicolaou; Aristomenis Thanos; George Trichonas; Xanthi Koufomichali; Kosisochukwu Anago; Patricia K Donahoe; Jose Teixeira; David T MacLaughlin; Demetrios Vavvas
Journal:  Protein Expr Purif       Date:  2009-09-13       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.